Context Deficits in advance care planning leave many patients and their phy
sicians unprepared for decisions about end-of-life care. Even though the pr
ognosis has im; proved for many persons with human immunodeficiency virus (
HIV) infection, a need for planning remains.
Objective To evaluate prevalence of end-of-life discussions, use of advance
directives, and preferences concerning end-of-life care and their relation
ship with patient demographics, clinical status, psychosocial variables, an
d practitioner characteristics among HIV-infected persons.
Design, Setting, and Patients Cross-sectional survey of a US probability sa
mple of 2864, which represents 231 400 adults receiving care for HIV, condu
cted from January 1996 to April 1997.
Main Outcome Measures Communication with physician regarding end-of-life is
sues, completion of an advance directive, preference for aggressiveness of
care,and willingness to tolerate future permanent adverse health states.
Results A total of 1432 patients (50%) discussed some aspect of end-of-life
care with their practitioner and 1088 (38%) completed an advance directive
. Patients were more likely to complete an advance directive after a physic
ian discussion (odds ratio [OR], 5.82; 95% confidence interval [CI], 4.50-7
.52). Practitioners discussed end-of-life care less with blacks (OR, 0.57;
95% CI, 0.39-0.83) and Latinos (OR, 0.74; 95% CI, 0.55-0.98) than with whit
es. Women (OR, 1.39; 95% CI, 1.05-1.84) and patients with children in the h
ousehold (OR, 1.53; 95% CI, 1.12-2.10) communicated the most with practitio
ners about end-of-life issues. Patients infected with HIV via injection dru
g use (OR, 0.64; 95% CI, 0.45-0.89) and those with less education communica
ted the least with physicians about end-of-life issues. Less denial, greate
r trust in one's practitioner, and longer patient-practitioner relationship
were associated with more advance care planning.
Conclusions: Half of all persons infected with HIV are at risk of making en
d-of-life decisions without prior discussions with their health care practi
tioners. Blacks, Latinos, intravenous drug users, and less educated individ
uals need advance care planning interventions in clinical HIV programs.